Arturo D Reyes of Goodrich Riquelme argues that enforcement of data exclusivity protection is possible in spite of the lack of precedent from the courts and limited provisions regarding its scope of ...

Marco Stief of Maiwald considers a regulatory proposal designed to promote antimicrobial R&D and address the ineffectiveness of patent protection, but points out that the proposal lacks clarity and ...

The government’s plans to introduce data exclusivity provisions in the country’s drug regulatory framework pose a risk to the generics market, and could likely create monopolies in the pharma sector, ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Tofacitinib - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)" report to their offering. Need ...

As the Central Drugs Standard Control Organisation (CDSCO) considers introducing data exclusivity provisions into India’s drug regulatory laws, healthcare activists warned that the move could delay ...

https://www.thehindubusinessline.com/news/keep-data-exclusivity-outside-the-regulatory-framework-public-health-voices-urge-the-centre/article70326580.ece Copy With ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/330598/bevacizumab_key) has announced the addition of the "Bevacizumab - Key ...

Patients’ rights groups warned on Wednesday that the Centre’s plans to introduce "data exclusivity" provisions into Indian drug regulations will delay the launch of new generic medicines and adversely ...

The Covid-19 pandemic reminded us that everyday life is full of interdependencies. The data models and logic for tracking the progress of the pandemic, understanding its spread in the population, ...

Data exclusivity (DE) creates a new system of monopoly power—not required under the TRIPS Agreement and separate from patents—that blocks the registration and marketing approval of generic medicines ...